These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11868523)

  • 41. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The influence of digoxin treatment on the statistical distribution of R-R intervals in atrial fibrillation].
    Tobiaszewska DC
    Pol Merkur Lekarski; 1999 Aug; 7(38):44-7. PubMed ID: 10522414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reducing stroke rates in patients with atrial fibrillation: how low can we go?
    Ezekowitz MD; Koti MJ; Fulton B
    Circulation; 2009 Sep; 120(13):1169-70. PubMed ID: 19752317
    [No Abstract]   [Full Text] [Related]  

  • 44. Edoxaban and amiodarone: interactions on multiple levels.
    Conen D
    Eur Heart J; 2015 Sep; 36(33):2210-1. PubMed ID: 26063449
    [No Abstract]   [Full Text] [Related]  

  • 45. [Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Cavuşoğlu Y
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):217-8; author reply 218-9. PubMed ID: 17513231
    [No Abstract]   [Full Text] [Related]  

  • 46. Atrial fibrillation (acute).
    Freestone B; Kamath S; Lip G
    Clin Evid; 2003 Jun; (9):61-71. PubMed ID: 15366136
    [No Abstract]   [Full Text] [Related]  

  • 47. Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers.
    Hansen ML; Gadsbøll N; Gislason GH; Abildstrom SZ; Schramm TK; Folke F; Friberg J; Sørensen R; Rasmussen S; Poulsen HE; Køber L; Madsen M; Torp-Pedersen C
    Europace; 2008 Apr; 10(4):395-402. PubMed ID: 18258807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Approach to management of atrial fibrillation in the Indian scenario.
    Vora A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():30-2. PubMed ID: 18368864
    [No Abstract]   [Full Text] [Related]  

  • 49. Atrial fibrillation (acute).
    Freestone B; Lip GY
    Clin Evid; 2004 Jun; (11):76-97. PubMed ID: 15652001
    [No Abstract]   [Full Text] [Related]  

  • 50. Rate control at least as effective as rhythm control for AF patients.
    Geriatrics; 2002 May; 57(5):63. PubMed ID: 12040594
    [No Abstract]   [Full Text] [Related]  

  • 51. Atrial fibrillation (recent onset).
    Lip GY
    Clin Evid; 2005 Dec; (14):71-89. PubMed ID: 16620401
    [No Abstract]   [Full Text] [Related]  

  • 52. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy of atrial fibrillation. Heart rate control is primary goal].
    MMW Fortschr Med; 2002 Oct; 144(40):48. PubMed ID: 12440299
    [No Abstract]   [Full Text] [Related]  

  • 54. Atrial fibrillation (acute).
    Freestone B; Lip GY
    Clin Evid; 2003 Dec; (10):76-94. PubMed ID: 15555087
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of anticoagulation in patients hospitalized with atrial fibrillation: warfarin is underused in paroxysmal atrial fibrillation.
    Marcu CB; Ghantous AE; Caracciolo EA; Donohue TJ
    Conn Med; 2003; 67(10):595-8. PubMed ID: 14677339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The association of warfarin use with osteoporotic fracture in elderly patients with atrial fibrillation.
    Cheng HY
    Arch Intern Med; 2006 Jul; 166(14):1525; author reply 1525. PubMed ID: 16864765
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute atrial fibrillation.
    Freestone B; Kamath S; Lip G
    Clin Evid; 2002 Jun; (7):1-10. PubMed ID: 12230635
    [No Abstract]   [Full Text] [Related]  

  • 59. A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need.
    Waldo AL
    Am Heart J; 2006 Apr; 151(4):771-8. PubMed ID: 16569531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Warfarin treatment in atrial fibrillation].
    Meland E
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2409; author reply 2409-10. PubMed ID: 16998561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.